The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

19 Jul 2005 18:09

Cubus Lux plc19 July 2005 CUBUS LUX PLC Board changes Directors' dealings Board changes Cubus Lux Plc ("Cubus" or the "Company") are pleased to announce the appointmentof Mr. Gerhard Huber (aged 45) and Mr. Michael Martin Janssen (aged 39) asexecutive chairman and non-executive director respectively. Gerhard Huber brings with him many years of experience in banking, real estatedevelopment and tourism in Croatia. Michael Janssen brings with him years ofexperience in financial management and investor relations. As part of these appointments, Moshe Har Adir has stepped down from his positionas executive CEO and director. Haggai Ravid has stepped down as interim chairmanand will remain a non-executive director. Mr. Gerhard Huber commented - "I am pleased to have the opportunity to bring inmy expertise to Cubus with our aim of growing it into the premier tourismcompany in Croatia." Details on directors Gerhard Huber Current directorshipsXelector Ltd Past directorshipsGSX Leisure Limited - a company which was put into liquidation. Michael Janssen Current directorshipsFAS AGCryptovision GmbHVC on Target GmbH Past directorshipsNone There are no further disclosures required to be made in respect of Mr. Huber andMr. Janssen with regard to paragraph (g) of Schedule 2 of the AIM Rules. Directors' dealings In conjunction with the board changes Mr. Har Adir has entered into an agreementto sell 9,878,763 ordinary shares, representing approximately 44.7% of theissued share capital of the Company to various entities and individuals,including Mr. Huber and Mr. Janssen. Completion of this share sale is due totake place on 22 July 2005, following which Mr. Huber and Mr. Janssen'sinterests in the Company will be as follows: Number of shares % of issued share capital Gerhard Huber 2,160,763 9.5%Michael Janssen 1,564,000 6.8% The Company is not currently subject to the City Code on Takeovers and Mergers. For information contact: Graham HerringThreadneedle Communications - 020 7531 2620 Olly CairnsCorporate Synergy Plc - 020 7626 2244 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Dec 20227:00 amRNSTR-1: Standard notification of major holdings
23rd Dec 20227:00 amRNSCellular Goods Annual Results
23rd Nov 20226:16 pmRNSTR-1: Standard notification of major holdings
2nd Nov 202210:34 amRNSTR-1: Standard notification of major holdings
24th Oct 20227:00 amRNSProducts launch on Debenhams.com
20th Oct 20227:00 amRNSLaunch of gift set collection for festive season
26th Sep 20227:00 amRNSProposed purchase of Cannaray Brands and Love CBD
23rd Sep 20225:49 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:47 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:42 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
21st Sep 20222:06 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSLaunch of three new skincare products
6th Sep 20227:00 amRNSPublication of new white paper
17th Aug 20227:00 amRNSGrant of Share Options
16th Aug 20227:00 amRNSAppointment of new Chief Financial Officer
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
4th Aug 20229:05 amRNSSecond Price Monitoring Extn
4th Aug 20229:00 amRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
2nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
2nd Aug 202211:05 amRNSSecond Price Monitoring Extn
2nd Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20222:00 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSUpdate on marketing initiatives and YouGov survey
11th Jul 20227:00 amRNSLaunch of minis
20th Jun 20227:00 amRNSLaunch of CBG and CBD petition
30th May 20227:00 amRNSInterim results
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
16th May 20222:05 pmRNSSecond Price Monitoring Extn
16th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20227:00 amRNSBoard changes
28th Apr 20227:00 amRNSInvestor presentation
28th Apr 20227:00 amRNSFirst patent application filed
22nd Apr 20226:04 pmRNSUpdate on ingestibles product range
22nd Apr 20227:00 amRNSWhite paper on lab-produced cannabinoids
13th Apr 20227:00 amRNSUpdate on ingestibles product range
11th Apr 20227:00 amRNSUpdate on ingestibles products
7th Apr 202210:24 amRNSTR-1: Standard notification of major holdings
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.